Contact UsHome

Presentations & Events

Presentations

Date	Documents
Apr 08, 2019	Add Files Aeglea BioTherapeutics Corporate Presentation 3.9 MB

Past Events

Date	Title
Summary Toggle Jun 04, 2018	Aeglea BioTherapeutics to Present at 2018 ASCO Annual Meeting Supporting Materials Phase 1 trial of Pegzilarginase in patients with relapsed/refractory (R/R) AML or MDS refractory to hypomethylating agents (HMAs) 1.8 MB
Summary Toggle Oct 16-20, 2018	American Society of Human Genetics (ASHG) Annual Meeting Title #1: Improvements in Arginase 1 Deficiency-related disease manifestations following plasma arginine reduction with pegzilarginase: early Phase 2 results Title #2: Improved survival and amelioration of disease-related liver pathology in a mouse model of homocystinuria with a novel homocysteine degrading enzyme Title #3: Clinical features of Arginase 1 Deficiency: Review of Literature Case Series Supporting Materials Improvements in Arginase 1 Deficiency Related Disease Manifestations Following Plasma Arginine Reductions With Pegzilarginase: Early Phase 2 Results 1.3 MB Clinical Features of Arginase 1 Deficiency: Review of a Literature Case Series 1.1 MB Improved Survival & Amelioration of Disease-Related Liver Pathology in a Mouse Model of Homocystinuria with a Novel Homocysteine Degrading Enzyme 2 MB
Summary Toggle Oct 21, 2018 1:35 PM CDT	European Society for Medical Oncology (ESMO) 2018 Congress Title: Initial cohort expansion results of sustained arginine depletion with pegzilarginase in melanoma patients in a Phase 1 advanced solid tumor trial Supporting Materials Initial cohort expansion results of sustained arginine depletion with Pegzilarginase in melanoma patients in a phase 1 advanced solid tumor trial 1.2 MB
Summary Toggle Oct 26, 2018 5:54 PM PDT	American Society of Nephrology (ASN) Supporting Materials Enzymatic Degradation of Cystine Decreases Nephrolithiasis in a Mouse Model of Cystinuria 1.6 MB
Summary Toggle Nov 09, 2018	Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting Supporting Materials Depletion of Plasma Arginine with Pegzilarginase (AEB1102) Enhances the Anti-Tumor Activity of Immune Checkpoint Inhibitors 1.7 MB
Summary Toggle Nov 09, 2018	Japanese Society for Inherited Metabolic Diseases 2018 Annual Meeting Supporting Materials Clinical Features of Arginase 1 Deficiency: Review of Global Literature 1.5 MB
Summary Toggle Apr 07, 2019 4:00 PM PDT	Society for Inherited Metabolic Disorders (SIMD) Annual Meeting Location Bellevue, Washington Supporting Materials Sustained Reductions in Plasma Arginine Following Pegzilarginase Administration in Patients with Arginase-1 Deficiency are Accompanied by Improvements in Mobility and Adaptive Behavior 807 KB
Summary Toggle Apr 08, 2019 8:30 AM EDT	Aeglea Biotherapeutics Clinical Data Update Conference Call Click here for webcast
Summary Toggle Apr 08, 2019 3:30 PM BST	H.C. Wainwright & Co., Global Life Sciences Conference Location London, England Click here for webcast
Summary Toggle Apr 10, 2019 10:00 AM EDT	Needham & Company 18th Annual Healthcare Conference Location New York, NY Click here for webcast